Physician profile
Blane Crandall
NPI 1326128109
$2,979.92
in general payments reported to CMS, 2019-2025
13 companies · $124 in 2025
The $124 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $768 · 2020: $507 · 2021: $895 · 2022: $400 · 2023: $135 · 2024: $151 · 2025: $124.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $410.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $410.04 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,410.06 | 2019-2024 | Ubrelvy, Qulipta, Lo Loestrin Fe |
| Amgen INC. | $244.99 | 2019 | |
| Biohaven Pharmaceuticals, INC. | $238.96 | 2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $230.22 | 2020-2022 | |
| Allergan, INC. | $153.62 | 2020 | |
| Biohaven Pharmaceutical Holding Company LTD. | $125.93 | 2022 | |
| Mayne Pharma Commercial LLC | $123.68 | 2025 | |
| Medtronic USA, INC. | $121.15 | 2020 | |
| Takeda Pharmaceuticals U.S.A., INC. | $114.67 | 2019 | |
| Lilly USA, LLC | $89.33 | 2019 | |
| Medtronic Vascular, INC. | $64.29 | 2019 | |
| Novartis Pharmaceuticals Corporation | $36.48 | 2019-2020 | |
| Hologic Sales and Service, LLC | $26.54 | 2024 | Aptima |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Blane Crandall listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.